Staphylococcus Aureus Nasal Carriage Clinical Trial
— CONASA 398Official title:
Nasal Carrying by Staphylococcus Aureus ST398 Strains in Community and Hospital Settings
Verified date | February 2019 |
Source | Centre Hospitalier Universitaire de Besancon |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The aim of this study was to compare the prevalence of nasal carrying of SA ST398 strains in community and hospital settings, identify the factors associated with colonization of SA ST398, determine the distribution of imported and acquired cases among SA ST398 hospital cases and characterize the genetic structure of the ST398 SA population involved in colonization.
Status | Not yet recruiting |
Enrollment | 2000 |
Est. completion date | September 2020 |
Est. primary completion date | April 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility |
For community patients : Inclusion Criteria: - the selection criteria for blood donation - age = 18 years old - No refusal of the person Exclusion Criteria: For hospitalized patients : Inclusion Criteria: - age = 18 years old - hospitalization in one of the services participating in the study - no refusal of the person Exclusion Criteria: |
Country | Name | City | State |
---|---|---|---|
France | CHU de Besançon | Besançon |
Lead Sponsor | Collaborator |
---|---|
Centre Hospitalier Universitaire de Besancon |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of patients nasal carrying of SA ST398 strains in community and hospital settings | Number of patients with SA ST398 positive nasal swab in community will be compared with number of patients with SA ST398 positive nasal swab in hospital | One day | |
Secondary | Number of patietns with specific Clinical and demographic data associated with nasal carrying of SA ST398 | Clinical and demographic (sex, age, gender, comorbidities, tabaco...) data will be compared between patients with SA ST398 positive nasal swab and SA ST398 negative nasal swab | One day | |
Secondary | Number of patients with SA ST398 positive nasal swab to seven days of hospitalization | Number of patients with SA ST398 positive nasal swab to seven days of hospitalization will be compared with the number of patients with SA ST398 positive nasal swab within the first 48 hours of hospitalization | 7 days | |
Secondary | Number of virulence gene in SA ST 398 strains | Presence of virulence gene in SA ST 398 strains | One day |